Technology Insight: Querying the genome with microarrays - Progress and hope for neurological disease

Nature Clinical Practice Neurology

Volumn 2, Issue 3, 2006, Pages 147-158

  Coppola, Giovanni ^a   Geschwind, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene resequencing; Microarrays; Neuro oncology; Neurodegenerative disorders; RNA transcript levels

Indexed keywords

MESSENGER RNA;

DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

GENOME, HUMAN; HUMANS; NERVOUS SYSTEM DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33644595247     PISSN: 1745834X     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpneuro0133     Document Type: Review

References (97)

1. Schena M et al. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470
2. Lockhart DJ et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680
3. NIH Neuroscience Microarray Consortium [http://arrayconsortium.tgen.org]
4. Ideker T (2004) Systems biology 101 - what you need to know. Nat Biotechnol 22: 473-475
5. Karsten SL and Geschwind DH (2002) Gene expression analysis using cDNA microarrays. Curr Prot Neurosci 4.28 (Suppl 20): S4.28.1-S4.28.28
6. Geschwind DH (2003) DNA microarrays: Translation of the genome from laboratory to clinic. Lancet Neurol 2: 275-282
7. Southern E et al. (1999) Molecular interactions on microarrays. Nat Genet 21: 5-9
8. Barlow C and Lockhart DJ (2002) DNA arrays and neurobiology - what's new and what's next? Curr Opin Neurobiol 12: 554-561
9. Mirnics K and Pevsner J (2004) Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7: 434-439
10. Stoughton RB (2005) Applications of DNA microarrays in biology. Annu Rev Biochem 74: 53-82
11. Pinkel D and Albertson DG (2005) Comparative genomic hybridization. Annu Rev Genomics Hum Genet 6: 331-354
12. Kennedy GC et al. (2003) Large-scale genotyping of complex DNA. Nat Biotechnol 21: 1233-1237
13. Hacia JG and Collins FS (1999) Mutational analysis using oligonucleotide microarrays. J Med Genet 36: 730-736
14. Geschwind DH (2000) Mice, microarrays, and the genetic diversity of the brain. Proc Natl Acad Sci USA 97: 10676-10678
15. Kita H et al. (2002) Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum Mol Genet 11: 2279-2287
16. Sipione S et al. (2002) Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 11: 1953-1965
17. Luthi-Carter R et al. (2002) Polyglutamine and transcription: Gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum Mol Genet 11: 1927-1937
18. Ross CA (2002) Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35: 819-822
19. Morton AJ et al. (2005) A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. Eur J Neurosci 21: 855-870
20. Ferrante RJ et al. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23: 9418-9427
21. Strand AD et al. (2005) Gene expression in Huntington's disease skeletal muscle: A potential biomarker. Hum Mol Genet 14: 1863-1876
22. Serra HG et al. (2004) Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum Mol Genet 13: 2535-2543
23. Colantuoni C et al. (2001) Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification. Neurobiol Dis 8: 847-865
24. Tudor M et al. (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99: 15536-15541
25. Traynor J et al. (2002) Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3: 12
26. Brown V et al. (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477-487
27. -/- mice. Hum Mol Genet 11: 547-557
28. Watase K and Zoghbi HY (2003) Modelling brain diseases in mice: The challenges of design and analysis. Nat Rev Genet 4: 296-307
29. Karsten SL and Geschwind DH (2005) Exercise your amyloid. Cell 120: 572-574
30. Middleton FA et al. (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22: 2718-2729
31. Mirnics K et al. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67
32. Mirnics ZK et al. (2003) DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes. Mol Psychiatry 8: 863-878
33. Mirnics K et al. (2005) Presenilin-1-dependent transcriptome changes. J Neurosci 25: 1571-1578
34. Lazarov O et al. (2005) Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 120: 701-713
35. Small SA et al. (2005) Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann Neurol 58: 909-919
36. Whitney LW et al. (1999) Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol 46: 425-428
37. Whitney LW et al. (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121: 40-48
38. Lock C et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508
39. Geschwind DH et al. (2001) A genetic analysis of neural progenitor differentiation. Neuron 29: 325-339
40. van Steensel B (2005) Mapping of genetic and epigenetic regulatory networks using microarrays. Nat Genet 37 (Suppl): S18-S24
41. Oldham MC et al. (2005) Network analysis of gene expression in human and chimpanzee brains identifies functional modules [abstract #409.8] Society for Neuroscience 35th Annual Meeting: 2005 November 12-16. Washington, DC: Society for Neuroscience
42. Zhang B and Horvath SA (2005) A general framework for weighted gene co-expression network analysis [article #17]. Statistical Applications in Genetics and Molecular Biology 4
43. Freije WA et al. (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64: 6503-6510
44. Mischel PS et al. (2004) DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 5: 782-792
45. Watts JA et al. (2002) Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am J Hum Genet 71: 791-800
46. Tang Y et al. (2001) Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease. Ann Neurol 50: 699-707
47. Tang Y et al. (2005) Blood gene expression profiling of neurologic diseases: A pilot microarray study. Arch Neurol 62: 210-215
48. Green NS and Pass KA (2005) Neonatal screening by DNA microarray: Spots and chips. Nat Rev Genet 6: 147-151
49. Nagasaka Y et al. (2005) A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc Natl Acad Sci USA 102: 14854-14859
50. Chee M et al. (1996) Accessing genetic information with high-density DNA arrays. Science 274: 610-614
51. Kallioniemi A et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
52. Pollack JR et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46
53. Lucito R et al. (2000) Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res 10: 1726-1736
54. Barrett MT et al. (2004) Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA 101: 17765-17770
55. Sharp AJ et al. (2005) Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77: 78-88
56. Sebat J et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528
57. Pinkel D and Albertson DG (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 (Suppl): S11-S17
58. Yu W et al. (2003) Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions. Hum Mol Genet 12: 2145-2152
59. Locke DP et al. (2003) Large-scale variation among human and great ape genomes determined by array comparative genomic hybridization. Genome Res 13: 347-357
60. Sellick GS et al. (2004) Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res 32: E164
61. Matsuzaki H et al. (2004) Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 14: 414-425
62. Hinds DA et al. (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307: 1072-1079
63. Altshuler D et al. (2005) A haplotype map of the human genome. Nature 437: 1299-1320
64. International HapMap Project [http://www.hapmap.org]
65. Klein RJ et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389
66. Arinami T et al. (2005) Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77: 937-944
67. Maraganore DM et al. (2005) High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77: 685-693
68. Gunderson KL et al. (2005) A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37: 549-554
69. Syvanen AC (2005) Toward genome-wide SNP genotyping. Nat Genet 37 (Suppl): S5-S10
70. Cutler DJ et al. (2001) High-throughput variation detection and genotyping using microarrays. Genome Res 11: 1913-1925
71. Maitra A et al. (2004) The Human MitoChip: A high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 14: 812-819
72. Tengs T et al. (2005) A transforming MET mutation discovered in non-small cell lung cancer using microarray-based resequencing. Cancer Lett
73. Mandal MN et al. (2005) Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci 46: 3355-3362
74. Takahashi Y et al. (2005) Development of DNA microarray-based high throughput gene analysis system for neurodegenerative diseases. Neurology 64 (Suppl 1): SA4
75. Margulies M et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380
76. Gohil K et al. (2003) Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic Biol Med 35: 1343-1354
77. D'Agata V et al. (2002) Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis 10: 211-218
78. Seznec H et al. (2005) Friedreich ataxia: The oxidative stress paradox. Hum Mol Genet 14: 463-474
79. Evert BO et al. (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol 62: 1006-1018
80. Lieuallen K et al. (2001) Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet 10: 1867-1871
81. Tan G et al. (2003) Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum Mol Genet 12: 1699-1711
82. Noguchi S et al. (2003) cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12: 595-600
83. Dickey CA et al. (2003) Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J Neurosci 23: 5219-5226
84. Reddy PH et al. (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13: 1225-1240
85. Yoshihara T et al. (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80: 158-167
86. Grunblatt E et al. (2001) Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J Neurochem 78: 1-12
87. Kalman J et al. (2005) Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr Genet 15: 1
88. Ginsberg SD et al. (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48: 77-87
89. Ho L et al. (2001) Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett 298: 191-194
90. Loring JF et al. (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol 20: 683-695
91. Colangelo V et al. (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70: 462-473
92. Blalock EM et al. (2004) Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101: 2173-2178
93. Jiang YM et al. (2005) Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57: 236-251
94. Satoh J et al. (2005) Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis 18: 537-550
95. Grunblatt E et al. (2004) Gene-expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111: 1543-1573
96. Hauser MA et al. (2005) Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 62: 917-921
97. Warrington JA et al. (2002) New developments in high-throughput resequencing and variation detection using high density microarrays. Hum Mutat 19: 402-409